PepTcell appoints Manfred Scheske as CEO of Consumer Health
PepTcell, a drug discovery group with an innovative mid- to late stage portfolio, announced the appointment of Manfred Scheske as Chief Executive Officer of Consumer Health.
Scheske, former President of Consumer Healthcare Europe at GlaxoSmithKline, is joining the Executive Team at PepTcell having enjoyed a highly successful 25-year career with GSK in Europe, North America and at a global level within GSK’s Consumer Healthcare Leadership Team.
Scheske, who was President of GSK’s £2 billion strong European Consumer Healthcare business from 2004 to 2010, also spent six years as President of GSK’s Consumer Healthcare business in North America. Amongst his successes was the launch of alli, GSK’s weight loss drug, which was the first pan-European switch from Rx to OTC. He built a market-leading position in the OTC smoking cessation market in the US and played a key role in the acquisition of Block Drug.
In his newly formed role at PepTcell, Scheske will have full responsibility for the consumer health portfolio. The leading products include a first-in-class cough suppressant with a clinically proven efficacy and safety profile. In addition, within the portfolio is a small molecule drug for inflammatory flare with a clinically proven safety analgesic profile entering Phase III trials.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
